Invitrogen Offers $300M in Convertible Notes to Repay Credit Line, Possibly Fund More M&A | GenomeWeb

NEW YORK, June 14 (GenomeWeb News) - Invitrogen said yesterday that it intends to offer $300 million of senior convertible notes due 2025.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.